journal article·2025-11-03Open access

Pre-Vascularized 3-Dimensional Skin Substitutes Promote Angiogenesis and Tissue Repair in a Murine Model of Refractory Skin Ulcers

Shota Tojo, Hiromi Miyazaki, Takami Saiki, Yasuyuki Tsunoi, Shingo Nakamura, Ryuichi Azuma

Journal of Functional Biomaterials· Volume 16· Issue 11

Abstract

Restoring blood flow is crucial for treating refractory ulcers. Despite advancements in various biomaterials, none incorporating pre-formed blood vessels have been commercialized. To address this, we developed a pre-vascularized three-dimensional (3D) skin substitute (PV-3D skin) designed to enhance healing when treating refractory ulcers. This study aimed to evaluate the therapeutic role of PV-3D skin transplantation in refractory ulcer models, induced by applying mitomycin C to wounds in severe immunodeficient mice. The wounds were then treated with PV-3D skin, non-vascularized 3D skin, skin grafts, or wound dressings. The PV-3D skin group demonstrated healing dynamics comparable to those of the skin graft group, with similar tissue morphology and wound temperature changes. Furthermore, at day 7 post-transplantation, the PV-3D skin group demonstrated significantly higher hypoxia-inducible factor 1-alpha expression levels compared to the 3D skin group. By day 14, the PV-3D skin group exhibited a significantly larger vascular area compared to the 3D skin group. Notably, PV-3D skin treatment stimulated host-derived angiogenesis, thereby enhancing wound healing and reducing the recurrence of refractory ulcers. These results suggest that PV-3D skin transplantation offers a promising therapeutic approach for refractory ulcers, especially in terms of angiogenesis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Plastic and Reconstructive Surgery, National Defense Medical College, Saitama 359-8513, Japan

Division of Biomedical Engineering, National Defense Medical College Research Institute, Saitama 359-8513, Japan

Division of Bioinformation and Therapeutic Systems, National Defense Medical College Research Institute, Saitama 359-8513, Japan

Funding

JSPS KAKENHI

References (49)

Show source-provided references
1. A randomized controlled trial of larval therapy for the debridement of leg ulcers: Results of a multicenter, randomized, controlled, open, observer blind, parallel group study10.1111/wrr.12127 ↗
2. Frequency of debridements and time to heal: A retrospective cohort study of 312 744 wounds10.1001/jamadermatol.2013.4960 ↗
3. Banakh, I., Cheshire, P., Rahman, M., Carmichael, I., Jagadeesan, P., Cameron, N.R., Cleland, H., and Akbarzadeh, S. (2020). A Comparative Study of Engineered Dermal Templates for Skin Wound Repair in a Mouse Model. Int. J. Mol. Sci., 21.10.3390/ijms21124508 ↗
4. Fu, H., Zhang, D., Zeng, J., Fu, Q., Chen, Z., Sun, X., Yang, Y., Li, S., and Chen, M. (2023). Application of 3D-printed tissue-engineered skin substitute using innovative biomaterial loaded with human adipose-derived stem cells in wound healing. Int. J. Bioprint, 9.10.18063/ijb.v9i2.674 ↗
5. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology10.1097/01.ASW.0000363485.17224.26 ↗
6. Burgess, J.L., Wyant, W.A., Abdo Abujamra, B., Kirsner, R.S., and Jozic, I. (2021). Diabetic Wound-Healing Science. Medicina, 57.10.3390/medicina57101072 ↗
7. Okonkwo, U.A., and DiPietro, L.A. (2017). Diabetes and Wound Angiogenesis. Int. J. Mol. Sci., 18.10.3390/ijms18071419 ↗
8. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers10.1002/dmrr.2742 ↗
9. Wound healing and treating wounds: Chronic wound care and management10.1016/j.jaad.2015.08.070 ↗
10. Miyazaki, H., Tsunoi, Y., Akagi, T., Sato, S., Akashi, M., and Saitoh, D. (2019). A novel strategy to engineer pre-vascularized 3-dimensional skin substitutes to achieve efficient, functional engraftment. Sci. Rep., 9.10.1038/s41598-019-44113-6 ↗
11. Fabrication of cellular multilayers with nanometer-sized extracellular matrix films10.1002/anie.200701089 ↗
12. Nagano, H., Suematsu, Y., Takuma, M., Aoki, S., Satoh, A., Takayama, E., Kinoshita, M., Morimoto, Y., Takeoka, S., and Fujie, T. (2021). Enhanced cellular engraftment of adipose-derived mesenchymal stem cell spheroids by using nanosheets as scaffolds. Sci. Rep., 11.10.1038/s41598-021-93642-6 ↗
13. Quantitative evaluation of skin barrier function using water evaporation time related to transepidermal water loss10.1111/srt.13242 ↗
14. Skin wound healing determined by water loss10.1016/0022-4804(85)90035-6 ↗
15. Skin graft monitoring using forward-looking infrared thermal imaging10.1111/iwj.70107 ↗
16. Skin microdialysis coupled with laser speckle contrast imaging to assess microvascular reactivity10.1016/j.mvr.2011.09.009 ↗
17. Applications of Laser Speckle Contrast Imaging Technology in Dermatology10.1016/j.xjidi.2023.100187 ↗
18. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging10.1161/CIRCIMAGING.111.970418 ↗
19. Laser speckle contrast imaging accurately measures blood flow over moving skin surfaces10.1016/j.mvr.2010.11.013 ↗
20. The role of fibroblast activation protein in health and malignancy10.1007/s10555-020-09909-3 ↗
21. Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix10.1111/j.1524-475X.2007.00258.x ↗
22. The effects of intradermal and topical mitomycin C on wound healing10.1016/j.otohns.2006.02.024 ↗
23. Study of wound healing in rats treated with topical and injected mitomycin C10.1177/000348940811701015 ↗
24. Enhanced healing of mitomycin C-treated healing-impaired wounds in rats with PRP-containing fragmin/protamine microparticles (PRP&F/P MPs)10.3109/2000656X.2015.1034723 ↗
25. The effect of platelet-rich fibrin on normal dermal fibroblast proliferation after mitomycin-c treatment: An in vitro study10.1016/j.amsu.2021.01.093 ↗
26. Mitomycin C: A clinical update10.1053/ctrv.2000.0202 ↗
27. Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence10.4161/cc.21506 ↗
28. Effect of mitomycin on normal dermal fibroblast and HaCat cell: An in vitro study10.1631/jzus.B1200055 ↗
29. Frueh, F.S., Spater, T., Korbel, C., Scheuer, C., Simson, A.C., Lindenblatt, N., Giovanoli, P., Menger, M.D., and Laschke, M.W. (2018). Prevascularization of dermal substitutes with adipose tissue-derived microvascular fragments enhances early skin grafting. Sci. Rep., 8.10.1038/s41598-018-29252-6 ↗
30. Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularization in dermal wounds10.1089/ten.tea.2012.0768 ↗
31. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease10.1161/ATVBAHA.111.230938 ↗
32. Tissue Engineering-Based Strategies for Diabetic Foot Ulcer Management10.1089/wound.2021.0081 ↗
33. Comparative Effectiveness of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real-World Setting10.1089/wound.2017.0738 ↗
34. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers10.1126/scitranslmed.aaf8611 ↗
35. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers10.1111/wrr.12778 ↗
36. The Role of Hypoxia-Inducible Factor in Wound Healing10.1089/wound.2013.0520 ↗
37. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair10.1111/j.1524-475X.2007.00278.x ↗
38. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice10.1073/pnas.0805230105 ↗
39. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha10.1152/ajpcell.2001.281.6.C1971 ↗
40. Chronic skin ulcers
41. Cellular and molecular composition of human skin in long-term xenografts on SCID mice10.1111/j.1600-0625.1993.tb00035.x ↗
42. Long-term maintenance of skin immune system in a NOD-Scid IL2rγ(null) mouse model transplanted with human skin10.1111/exd.12530 ↗
43. Macrophage activation and innate resistance to infection in SCID mice10.1016/S0171-2985(11)80448-1 ↗
44. Jimi, S., Kimura, M., De Francesco, F., Riccio, M., Hara, S., and Ohjimi, H. (2017). Acceleration Mechanisms of Skin Wound Healing by Autologous Micrograft in Mice. Int. J. Mol. Sci., 18.10.3390/ijms18081675 ↗
45. Kim, S.W., Zhang, H.Z., Guo, L., Kim, J.M., and Kim, M.H. (2012). Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS ONE, 7.10.1371/annotation/f6ebe3d3-ef7c-42ce-86fe-d5a661d7f67f ↗
46. Evolution of ischemia and neovascularization in a murine model of full thickness human wound healing10.1111/wrr.12847 ↗
47. A small molecule HIF-1α stabilizer that accelerates diabetic wound healing10.1038/s41467-021-23448-7 ↗
48. A Bilayer Engineered Skin Substitute for Wound Repair in an Irradiation-Impeded Healing Model on Rat10.1089/wound.2014.0551 ↗
49. Autologous blood transfusion stimulates wound healing in diabetic mice through activation of the HIF-1α pathway by improving the blood preservation solution10.1096/fj.201900324RRR ↗